Literature DB >> 4018

NADPH-cytochrome P450 reductase.

T Matsubara, J Baron, L L Peterson, J A Peterson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 4018     DOI: 10.1016/0003-9861(76)90099-0

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


× No keyword cloud information.
  5 in total

1.  Inhibition of cytochrome P-450-dependent mixed function oxidation by ethanol.

Authors:  N Hayashi; T Kamada; N Sato; A Kasahara; J A Peterson
Journal:  Dig Dis Sci       Date:  1985-04       Impact factor: 3.199

2.  Influence of liver disease and environmental factors on hepatic monooxygenase activity in vitro.

Authors:  M J Brodie; A R Boobis; C J Bulpitt; D S Davies
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

3.  Kinetics of electron transfer in the complex of cytochrome P450 3A4 with the flavin domain of cytochrome P450BM-3 as evidence of functional heterogeneity of the heme protein.

Authors:  Harshica Fernando; James R Halpert; Dmitri R Davydov
Journal:  Arch Biochem Biophys       Date:  2007-12-07       Impact factor: 4.013

4.  Variability in Loss of Multiple Enzyme Activities Due to the Human Genetic Variation P284T Located in the Flexible Hinge Region of NADPH Cytochrome P450 Oxidoreductase.

Authors:  Shaheena Parween; Maria Natalia Rojas Velazquez; Sameer S Udhane; Norio Kagawa; Amit V Pandey
Journal:  Front Pharmacol       Date:  2019-10-15       Impact factor: 5.810

5.  Altered CYP19A1 and CYP3A4 Activities Due to Mutations A115V, T142A, Q153R and P284L in the Human P450 Oxidoreductase.

Authors:  Sameer S Udhane; Shaheena Parween; Norio Kagawa; Amit V Pandey
Journal:  Front Pharmacol       Date:  2017-08-25       Impact factor: 5.810

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.